Learning Hub: Webinars

Rapid Diagnostics for Respiratory Illnesses Protect Patients and Strengthen Community Health

As respiratory illnesses rise in the colder months, it’s essential for clinicians to provide patients with the care they need and help them take the necessary precautions to keep themselves and their communities safe.

Reimagining Rural Healthcare

Rural healthcare facilities across the US are facing a triple threat: overextended budgets, staffing shortages, and a higher burden of need. We spoke with Audra Jones, SVP Head of North America at QuidelOrtho, about the Certified Analyzer Program and how it aims to reduce healthcare disparities and expand access to high-quality diagnostic testing with refurbished analyzers.

How Rapid Diagnostics Are Changing Overdose Response in the Synthetic Opioid Crisis

In 2024, overdose deaths in the U.S. fell by nearly 30,000 from the year before, according to the U.S. Centers for Disease Control and Prevention.

Managing Legacy Medical Devices That Can No Longer Be Patched

Patty Ryan discusses how the long lifecycles of medical devices impact cybersecurity in healthcare environments.

Rapid Diagnostics for Respiratory Illnesses Protect Patients and Strengthen Community Health

As respiratory illnesses rise in the colder months, it’s essential for clinicians to provide patients with the care they need and help them take the necessary precautions to keep themselves and their communities safe.

Reimagining Rural Healthcare

Rural healthcare facilities across the US are facing a triple threat: overextended budgets, staffing shortages, and a higher burden of need. We spoke with Audra Jones, SVP Head of North America at QuidelOrtho, about the Certified Analyzer Program and how it aims to reduce healthcare disparities and expand access to high-quality diagnostic testing with refurbished analyzers.

How Rapid Diagnostics Are Changing Overdose Response in the Synthetic Opioid Crisis

In 2024, overdose deaths in the U.S. fell by nearly 30,000 from the year before, according to the U.S. Centers for Disease Control and Prevention.

Managing Legacy Medical Devices That Can No Longer Be Patched

Patty Ryan discusses how the long lifecycles of medical devices impact cybersecurity in healthcare environments.

Back-to-School Season and the Surge in Respiratory Illness: Why Diagnostics Matter

From daycare to college, the back-to-school season almost always correlates to one thing: a rise in respiratory illnesses. In late summer, when children are returning to their classrooms, outbreaks of illnesses like strep throat, influenza, COVID-19 and respiratory syncytial virus (RSV) become more common, and schools can quickly become amplifiers of community transmission.1 These infections can spread rapidly through contact with surfaces where the virus or bacteria is present, like desks, staircase railings and even supplies shared across classrooms. A lack of preventative measures, including people not covering their noses or mouths when coughing or sneezing further contribute to spreading of the infections.

Adapting Security With Clear Risk Awareness and Team Support

Patty Ryan is the Chief Information Security Officer at QuidelOrtho, where they lead the company’s global information security strategy and operations. With prior experience as CISO at Ortho Clinical Diagnostics, Ryan brings expertise in security architecture, risk management and governance. His focus spans secure design for systems and products, threat detection and identity management to ensure resilient and compliant operations across the enterprise.

Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in the Emergency Department

In the emergency department, the line between life and death can blur in a matter of minutes. When a patient is rushed in for acute intoxication – barely conscious, breathing shallowly, lips turning blue – clinicians are thrust into a high-stakes puzzle. The culprit could be fentanyl, xylazine, nitazenes or a dangerous mix of them all. In this chaotic environment, compounded by increasing use of deadlier drugs, early diagnostics and continuous monitoring aren’t just helpful – they’re essential.

How to Detect and Manage Preeclampsia During Pregnancy

Imagine you’re in the third trimester of your first pregnancy. You’re healthy. Everything has gone well so far, nothing out of the ordinary. Then, seemingly without warning, you begin experiencing intermittent shortness of breath, swelling in the hands and face, blurred vision, headaches, and stomach pains that don’t go away. The experience is alarming, to say the least. Unfortunately, for an increasing number of women facing preeclampsia during pregnancy, these symptoms and the serious risks they signal, are an escalating concern.

The Key to Controlling Sexually Transmitted Infections: Early Diagnosis

Sexually transmitted infections (STIs) are surging worldwide, posing a significant public health threat. The consequences of delayed diagnosis range from individual health complications to increased transmission rates, and even antibiotic resistance. Yet, many STIs remain underdiagnosed due to their asymptomatic nature. Let’s explore the critical importance of early diagnosis, the rise in STI cases and the latest advancements in diagnostic technologies available to curb the rise of infection.

Sepsis Diagnosis Is Critical in the Age of Antibiotic Resistance

Sepsis is a life-threatening emergency caused by the body’s extreme response to infection, requiring rapid diagnosis and treatment to prevent organ failure and death.

QuidelOrtho introduces Results Manager System

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories. This system offers a streamlined, user-friendly interface for community hospitals and point-of-care settings, enhancing the informatics capabilities across QuidelOrtho's broad range of diagnostic tools. The QuidelOrtho Results Manager System provides continuous tracking of instruments and assays, simplifying workflows with features like auto-verification and intuitive rule-writing tools.

Informatics Solution Elevates Laboratory Efficiency and Patient Care

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories. This system offers a streamlined, user-friendly interface for community hospitals and point-of-care settings, enhancing the informatics capabilities across QuidelOrtho's broad range of diagnostic tools. The QuidelOrtho Results Manager System provides continuous tracking of instruments and assays, simplifying workflows with features like auto-verification and intuitive rule-writing tools.

Results Manager System Introduced by QuidelOrtho

QuidelOrtho Corporation has launched the QuidelOrtho Results Manager System, an informatics solution designed to enhance efficiency, connectivity, and clinical decision-making in modern laboratories.

Patient care and the cost of turnover in the clinical laboratory

Businesses of every size and industry are highly sensitive to the impact of staff turnover. For hospitals and health care organizations, navigating the monetary costs and operational effects can be especially challenging, particularly with high-demand, lower-paid positions such as medical technologists in the clinical laboratory. Learn more.

Emergency Cardiac Care: Diagnosing Faster When Every Second Counts

In an emergency room, decisions happen fast. A patient arrives with chest pain. Doctors, nurses, and staff move quickly, assessing symptoms, ordering tests, and preparing for the worst while hoping for the best. In cardiac emergencies, every second holds the power to save a life. Learn more.

How the U.S. blood supply provides a lifeline to patients across the nation

Every two seconds someone in the U.S. needs blood. Whether it is for life-saving surgeries, transfusions for traumatic injuries, or for chronic diseases like hepatitis, sickle cell anemia and cancer, the U.S. blood supply is an essential part of the healthcare system and a lifeline for patients and their families. In this article, we’ll explore the interdependencies of the U.S. blood supply, and how through the compassion of donors in collaboration with hospitals and healthcare providers, the system helps save lives and makes everyday miracles possible. Learn more.

What’s Behind Today’s Clinical Laboratory Staffing Shortage?

Six Sigma in Clinical Labs: Data Leads to Changes in Quality Control

Saint Peter’s Healthcare System got a crash course on the benefits of Six Sigma in clinical labs thanks to a data-based project with an in vitro diagnostics (IVD) supplier.

CyberEdBoard Profiles in Leadership: Patty Ryan

Tracking — and Tackling — the Recent Resurgence of Syphilis

The Importance of Utilizing Tools like AI-based Analytic Solutions

CLINICAL24: QuidelOrtho’s breakthrough fentanyl solution for the opioid crisis

A Novel Approach For Routinely Assessing Laboratory Sigma Metrics For A Broad Range of Automated Assays

Peer reviewed article: A Novel Approach for Routinely Assessing Laboratory Sigma Metrics for a Broad Range of Automated Assays. Sigma metrics have been adapted for the clinical laboratory to incorporate observed accuracy, precision, and total error allowed. The higher the Sigma level for a process, the better performance that process has. A limitation of studies assessing Sigma metrics is that they are performed on a small number of well-controlled systems. Read more.

Jets Partnered With QuidelOrtho and American Red Cross to Host Holiday Blood Drive

The New York Jets and QuidelOrtho Corporation ("QuidelOrtho") hosted a blood drive with the American Red Cross on Monday, December 12. Staff members of the Jets and QuidelOrtho joined local community members to donate blood this holiday season. The blood drive collected 27 pints of blood, which can help save approximately 80 lives.

Ortho® Workstation Earns AABB Quality Seal

First product of its kind awarded by the AABB’s Standards-Compliant Product Program

QuidelOrtho Joins Alliance for a Strong Blood Supply Launched by Association for the Advancement of Blood & Biotherapies

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho” or the “Company”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it is joining the Alliance for a Strong Blood Supply (the “Alliance”). The Alliance is a coalition founded by the Association for the Advancement of Blood & Biotherapies (“AABB”) that includes a group of partner organizations committed to ensuring sufficient blood is available for all patients during the pandemic and beyond.

QuidelOrtho provides easier, faster test results with new molecular platform

In this Repertoire Podcast, Repertoire Magazine publisher Scott Adams is joined by Tammi Ranalli, the Senior Vice President of Molecular Diagnostics for the QuidelOrtho Corporation to discuss QuidelOrtho’s new molecular diagnostic innovation, the Savanna. “This has really been an over 10-year labor of love for me,” Ranalli said about the new cartridge-based molecular platform.

Quidel Named First Partner at SDSU Mission Valley Innovation District, Founding Partner at Snapdragon Stadium

San Diego State University announced today the execution of partnership agreements with Quidel Corporation (“Quidel”), a subsidiary of QuidelOrtho Corporation (NASDAQ: QDEL) and a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, that will make Quidel the first partner in SDSU Mission Valley’s Innovation District and a Founding Partner at SDSU’s Snapdragon Stadium, the new home of Aztec football.

Opinion: Here’s how San Diego biotech helped fight the COVID-19 pandemic

Countless academic and research institutions, companies and organizations working on life sciences and biotechnology are woven into the city’s fabric

2022 AACC Annual Scientific Meeting + Clinical Lab Expo

Quidel Corporation and Ortho Clinical Diagnostics to exhibit at the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo

How Quidel Navigated COVID-19: A conversation with Quidel President and CEO Doug Bryant

How Quidel Navigated COVID-19: A conversation with Quidel President and CEO Doug Bryant

Ortho Recently Featured as a Corporate Partner in the AABB Monthly Magazine

Maximizing the Benefits of COVID-19 Vaccines With the Right Serological Tests

Ortho’s CE-Marked VITROS^® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals

North America Downloadable Resources

What is SARS-CoV-2 (Coronavirus)?

SARS-CoV-2 Total Assay Recently Validated by the Centre National de Référence (Institut Pasteur et Hospices Civils de Lyon) with 100% specificity

e-Connectivity® Technology for ORTHO VISION® Analyzers

How Ortho’s VITROS® XT Solutions Were Inspired by an Important Constituency: Our Customers

Why the Laboratory Is at the Forefront of the Global Fight Against HIV

Ortho Clinical Brings New Tech to World of Medical Diagnostics

Diagnostics’ Waterless Wave: An Ortho Customer Case Study

Ortho Gets CE Mark for Slides That Run 2 IVD Tests Off a Single Blood Sample

Ortho Clinical Diagnostics Revolutionizes Lab Tech